RDNT Company Profile and Key Details

Q: Who are the executives of RDNT?

Ms. Christine Nayoma GordonSenior Vice President of Operations - Northern California & DirectorMs. Laura Foster BSRT, MPH, J.D.Senior Vice President of Compliance & Regulatory AffairsMr. Stephen M. ForthuberPres & Chief Operating Officer of Eastern OperationsMs. Ruth Louisa Villiger-WilsonHR Advisor & DirectorDr. Howard G. Berger M.D.Chairman, Pres & Chief Executive OfficerMr. Norman R. HamesPres & Chief Operating Officer of Western OperationsMr. Mark D. StolperExecutive Vice President & Chief Financial OfficerMr. Michael M. MurdockExecutive Vice President of Mergers & AcquisitionsMr. David Jeffrey KatzExecutive Vice President, Chief Legal Officer & Corporation Sec.Mr. Ranjan JayanathanExecutive Vice President, Chief Information Officer & GM of eRAD - Radiology Information Technology DivisionMr. Mital PatelExecutive Vice President of Financial Planning & Analysis and Chief Admin. Officer

NASDAQ : RDNT

RadNet

$69.15

-0.09-0.13%

At Close 4:00 PM

68.42

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

RadNet, Inc. (RDNT) stock declined over -0.13%, trading at $69.15 on NASDAQ, down from the previous close of $69.24. The stock opened at $68.52, fluctuating between $68.42 and $70.40 in the recent session.

Stock Snapshot

69.24

Prev. Close

5.35B

Market Cap

68.42

Day Low

-432.19

P/E Ratio

-0.16

EPS (TTM)

0.65

Cash Flow per Share

68.52

Open

77.39M

Number of Shares

70.4

Day High

89.99%

Free Float in %

9.29

Book Value

574.61K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 09, 2026	69.00	70.40	68.04	69.15	588.05K
Feb 06, 2026	66.54	69.46	63.99	69.24	1.43M
Feb 05, 2026	68.40	68.82	64.50	64.52	1.15M
Feb 04, 2026	70.25	70.25	67.16	67.68	655.84K
Feb 03, 2026	70.75	72.75	69.05	70.11	766.58K
Feb 02, 2026	70.04	70.94	69.31	70.87	583.15K
Jan 30, 2026	70.58	71.91	69.50	70.10	875.3K
Jan 29, 2026	71.37	72.23	69.40	70.71	669.98K
Jan 28, 2026	72.38	73.34	70.98	71.66	457.33K
Jan 27, 2026	73.87	74.12	70.37	72.50	475.52K
Jan 26, 2026	72.98	74.16	72.06	74.10	443.32K
Jan 23, 2026	72.65	73.36	70.85	73.17	530.43K
Jan 22, 2026	72.73	75.01	72.40	72.97	609.04K
Jan 21, 2026	71.20	72.22	69.68	72.00	693.43K
Jan 20, 2026	69.80	71.63	69.50	70.45	632.4K
Jan 16, 2026	72.83	73.19	70.84	70.99	626.07K
Jan 15, 2026	72.69	73.93	70.54	72.99	1.05M
Jan 14, 2026	73.98	74.08	71.87	72.90	886.58K
Jan 13, 2026	76.44	76.67	73.28	74.14	624.1K
Jan 12, 2026	77.13	77.85	75.81	76.35	551.8K

Contact Details

Los Angeles, CA 90025-3303

United States

https://www.radnet.com 310 478 7808

About Company

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Stock Peers

IDXX

-4.82-0.75%

IDEXX Laboratories, Inc.$639.79 MEDP

-11.69-2.16%

Medpace Holdings, Inc.$530.35 NTRA

7.54+3.71%

Natera, Inc.$210.58 ICLR

3.98+2.64%

ICON Public Limited Company$154.57 ILMN

-2.47-2.06%

Illumina, Inc.$117.25 GH

3.49+3.43%

Guardant Health, Inc.$105.34 EXAS

0.14+0.14%

Exact Sciences Corporation$103.32 GRAL

0.33+0.33%

GRAIL, Inc.$100.40 BLLN

1.8+1.99%

BillionToOne, Inc.$92.41 TWST

-1.77-3.59%

Twist Bioscience Corporation$47.47

Company Overview

RadNet, Inc. (NASDAQ:RDNT) closed at $69.15 USD, losing -$0.09 (-0.13%) from the previous close of $69.24. The stock is currently mid-range between its 52-week high and low $45.00 and $85.84. With a market capitalization of about $5.35 billion, RadNet, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.49). Key stats such as the average daily volume over the past year has been around 883.87 thousand shares, volume is running light vs its 52-week average. Headquartered in Los Angeles, CA, RadNet, Inc. operates in the Healthcare sector and the Medical - Diagnostics & Research industry. Led by CEO Howard G. Berger, the company employs approximately 11,000 people and listed since January 03, 1997. RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -3.06%, SMA50 -6.57%, SMA200 1.88%). The stock’s 14-day RSI is 43.45 (neutral), while the ATR of 3.04 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -19.44% below its high and over 53.66% above its low. Average 10-day trading volume of 865.12 thousand shares is in line with the 3-month average of 858.90 thousand, indicating normal recent market interest.

Valuation Metrics

RadNet, Inc. trades at a P/E ratio of -410.37, slightly below the S&P 500 average, with a price-to-sales ratio of 2.74 and a price-to-book ratio of 4.93 trading at moderately above to book value. The P/FCF stands at 103.8, also below market averages.

Dividend & Fair Value

RadNet, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$8.52. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

RadNet, Inc. generated EPS of -$0.18 over the past year. Five-year average earnings growth is -33.78%. The latest quarter delivered EPS of $0.20. The next quarter is forecast at $0.20. Next year's EPS is expected at $71.09. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $92.00 to $60.00. The high target offers 33.04% upside. The low target suggests -13.23% downside. The mean target is $78.40. This offers 13.38% upside. RadNet, Inc. earnings surprise history is a mixed track record. The quarter that ended November 10, 2025, missed forecasts by -13.04%. The prior quarter beat by -72.11%. Over the last six quarters, Apple has recorded several small beats. These include -13.33% in November 10, 2024.

Shareholding & Insider Activity

RadNet, Inc. has 76.92 million shares outstanding. The public float is 69.18 million shares, elevated short interest at 9.15% of float. This equals 5.96 million shares. The short ratio is 6.01 days. Institutional investors hold 107.93% of the float. Insiders own 12.73%. Sorensen Alma Gregory holds 1.16 million shares, LINDEN JEFFREY L has 902.00 thousand shares and Forthuber Stephen M has 529.22 thousand shares. Over the past six months, insider transactions show net selling. They sold 200.80 thousand shares across 13 transactions.

Financial & Profitability Overview

Over the trailing twelve months, RadNet generated $1.62B in revenue, or $25.00 per share. Gross margin was 5.75%, operating margin 5.75%, and net profit margin 0.19%. Returns are modest, with ROA at 0.11% and ROE at 0.48%.
On valuation metrics, RadNet trades at a P/E of -410.37, P/S of 2.74 and P/B of 4.93. The current ratio is 1.87 and quick ratio is 1.87. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is -48.70 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 1.75, supported by a cash flow-to-debt ratio of 0.14.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, RadNet posted revenue of $1.62B, down slightly from $1.43B in the prior quarter. Gross profit was $93.00M (margin 5.75%). Operating income was $93.00M (margin 5.8%). Net income was$3.04M (EPS $0.05).
The company ended the quarter with $342.57M in cash and short-term investments, a total debt of $1.49B, and net debt of $1.15B. Total assets were $2.89B, with equity of $813.36M. Financials further reflected stability, with operating cash flow of $220.86M, free cash flow of $44.26M, and capital expenditures of - $176.60M.

Price Forecast & Outlook

Our AI price prediction model suggests that RadNet, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.94%, with price expected at $64.35 by February 20, 2026, within a range of $62.01 to $66.95 1-Year Outlook: Projected gain of 19.9%, with price at $82.91 by February 05, 2027, within a range of $79.83 to $86.43.

Key Takeaways

RadNet, Inc. (NASDAQ:RDNT) shares are flat -1.26% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows RadNet, Inc. trading at a premium to the broader market with a P/E of -410.37. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $54.61, suggesting -21.03% downside.

Frequently Asked Questions

What is the current RadNet, Inc. (RDNT) stock price?

RadNet, Inc. (NASDAQ: RDNT) stock price is $69.15 in the last trading session. During the trading session, RDNT stock reached the peak price of $70.40 while $68.42 was the lowest point it dropped to. The percentage change in RDNT stock occurred in the recent session was -0.13% while the dollar amount for the price change in RDNT stock was - $0.09.

RDNT's industry and sector of operation?

The NASDAQ listed RDNT is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. RadNet, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RDNT?

Ms. Christine Nayoma Gordon
Senior Vice President of Operations - Northern California & Director
Ms. Laura Foster BSRT, MPH, J.D.
Senior Vice President of Compliance & Regulatory Affairs
Mr. Stephen M. Forthuber
Pres & Chief Operating Officer of Eastern Operations
Ms. Ruth Louisa Villiger-Wilson
HR Advisor & Director
Dr. Howard G. Berger M.D.
Chairman, Pres & Chief Executive Officer
Mr. Norman R. Hames
Pres & Chief Operating Officer of Western Operations
Mr. Mark D. Stolper
Executive Vice President & Chief Financial Officer
Mr. Michael M. Murdock
Executive Vice President of Mergers & Acquisitions
Mr. David Jeffrey Katz
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Ranjan Jayanathan
Executive Vice President, Chief Information Officer & GM of eRAD - Radiology Information Technology Division
Mr. Mital Patel
Executive Vice President of Financial Planning & Analysis and Chief Admin. Officer

How RDNT did perform over past 52-week?

RDNT's closing price is 53.66% higher than its 52-week low of $45.00 where as its distance from 52-week high of $85.84 is -19.44%.

How many employees does RDNT have?

Number of RDNT employees currently stands at 11,000.

Link for RDNT official website?

Official Website of RDNT is: https://www.radnet.com

How do I contact RDNT?

RDNT could be contacted at phone 310 478 7808 and can also be accessed through its website. RDNT operates from 1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA 90025-3303, United States.

How many shares of RDNT are traded daily?

RDNT stock volume for the day was 574.61K shares. The average number of RDNT shares traded daily for last 3 months was 883.87K.

What is the market cap of RDNT currently?

The market value of RDNT currently stands at $5.35B with its latest stock price at $69.15 and 77.39M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	11000
Beta	1.49
Sales or Revenue	$1.62B
5Y Sales Change%	0.255%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Diagnostics & Research

RDNT Company Profile and Key Details

RadNet

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics